ABSTRACT
Abstract..............................................................................................................344 20.1 Introduction..............................................................................................344 20.2 Studies of Neuroprotective Properties in Models of
Parkinson’s Disease .................................................................................345 20.2.1 Antioxidant Agents ......................................................................345 20.2.2 Rasagiline.....................................................................................347
20.3 Neuroprotective Studies in Models of Alzheimer’s Disease ...................348 20.3.1 Antioxidant Agents ......................................................................348 20.3.2 Rasagiline.....................................................................................348
20.4 The Mechanisms Underlying Antioxidant-Attenuated Cell Death .........349 20.4.1 Modulation of Cell Signaling Pathways......................................349 20.4.2 Effect of Antioxidants on Cell Survival/Death Gene
